Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer

被引：35
|
作者：
Barroso-Sousa, Romualdo
Jain, Esha
Kim, Dewey
Partridge, Ann H.
Cohen, Ofir
Wagle, Nikhil
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Broad Inst MIT & Harvard, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1010
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tumor mutational burden (TMB) and BCG responsiveness in high-risk non-muscle invasive bladder cancer (NMIBC).
    Bastos, Diogo Assed
    Lima, Mariana
    Mattedi, Romulo Loss
    dos Santos, Filipe Ferreira
    Buzatto, Vanessa
    Barreiro, Rodrigo
    Ribeiro-Filho, Leopoldo
    Cordeiro, Mauricio
    Amano, Mariane
    Souza, Jussara Michaloski
    Bettoni, Fabiana
    Favoretto Galante, Pedro Alexandre
    Dzik, Carlos
    Nahas, William Carlos
    Camargo, Anamaria Aranha
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [42] Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
    Sammons, Sarah
    Elliott, Andrew
    Barroso-Sousa, Romualdo
    Chumsri, Saranya
    Tan, Antoinette R.
    Sledge, George W.
    Tolaney, Sara M.
    Torres, Evanthia T. Roussos
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
    Sammons, Sarah
    Elliott, Andrew
    Force, Jeremy
    Chumsri, Saranya
    Anders, Carey
    Tan, Antoinette R.
    Magee, Daniel
    Zeng, Jia
    Korn, W. Michael
    Kahsraw, Mustafa
    Torres, Evanthia T. Roussos
    CANCER RESEARCH, 2022, 82 (04)
  • [44] High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity
    Karamitopoulou, Eva
    Andreou, Andreas
    Wenning, Anna Silvia
    Gloor, Beat
    Perren, Aurel
    EUROPEAN JOURNAL OF CANCER, 2022, 169 : 64 - 73
  • [45] Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
    Hellmann, M. D.
    Ciuleanu, T. -E.
    Pluzanski, A.
    Lee, J. S.
    Otterson, G. A.
    Audigier-Valette, C.
    Minenza, E.
    Linardou, H.
    Burgers, S.
    Salman, P.
    Borghaei, H.
    Ramalingam, S. S.
    Brahmer, J.
    Reck, M.
    O'Byrne, K. J.
    Geese, W. J.
    Green, G.
    Chang, H.
    Szustakowski, J.
    Bhagavatheeswaran, P.
    Healey, D.
    Fu, Y.
    Nathan, F.
    Paz-Ares, L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2093 - 2104
  • [46] Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project
    Vega, D. M.
    Yee, L. M.
    McShane, L. M.
    Williams, P. M.
    Chen, L.
    Vilimas, T.
    Fabrizio, D.
    Funari, V.
    Newberg, J.
    Bruce, L. K.
    Chen, S. -j.
    Baden, J.
    Barrett, J. Carl
    Beer, P.
    Butler, M.
    Cheng, J. -h.
    Conroy, J.
    Cyanam, D.
    Eyring, K.
    Garcia, E.
    Green, G.
    Gregersen, V. R.
    Hellmann, M. D.
    Keefer, L. A.
    Lasiter, L.
    Lazar, A. J.
    Li, M. -c.
    MacConaill, L. E.
    Meier, K.
    Mellert, H.
    Pabla, S.
    Pallavajjalla, A.
    Pestano, G.
    Salgado, R.
    Samara, R.
    Sokol, E. S.
    Stafford, P.
    Budczies, J.
    Stenzinger, A.
    Tom, W.
    Valkenburg, K. C.
    Wang, X. Z.
    Weigman, V.
    Xie, M.
    Xie, Q.
    Zehir, A.
    Zhao, C.
    Zhao, Y.
    Stewart, M. D.
    Allen, J.
    ANNALS OF ONCOLOGY, 2021, 32 (12) : 1626 - 1636
  • [47] Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
    Thomas, Alexandra
    Routh, Eric D.
    Pullikuth, Ashok
    Jin, Guangxu
    Su, Jing
    Chou, Jeff W.
    Hoadley, Katherine A.
    Print, Cristin
    Knowlton, Nick
    Black, Michael A.
    Demaria, Sandra
    Wang, Ena
    Bedognetti, Davide
    Jones, Wendell D.
    Mehta, Gaurav A.
    Gatza, Michael L.
    Perou, Charles M.
    Page, David B.
    Triozzi, Pierre
    Miller, Lance D.
    ONCOIMMUNOLOGY, 2018, 7 (10):
  • [48] Overestimation of tumor mutational burden (TMB) using algorithms compared to germline subtraction.
    Parikh, Kaushal
    Huether, Robert
    White, Kevin
    Hoskinson, Derick
    Dong, Haidong
    Adjei, Alex A.
    Mansfield, Aaron Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Clinical, pathologic, and molecular associations of tumor mutational burden in metastatic breast cancer
    Mohamed, Mohamed A.
    Wang, Chenghuang
    Buckley, Morgan
    Lehman, Jennifer
    Canzoniero, Jenna
    Gocke, Christopher D.
    Nunes, Raquel
    Park, Ben Ho
    Smith, Karen L.
    Tao, Jessica
    Tukachinsky, Hanna
    Wilkinson, Mary
    Wolff, Antonio C.
    Stearns, Vered
    Santa-Maria, Cesar A.
    CANCER RESEARCH, 2022, 82 (04)
  • [50] Barriers to tumor mutational burden (TMB) testing in oncology care - US Physician Survey
    Jones, Gieira
    Szamreta, Elizabeth
    Jackson, Bianca
    Ning, Ning
    Stephens, Jennifer
    Hussain, Arif
    CANCER RESEARCH, 2024, 84 (06)
12345